Status:

NOT_YET_RECRUITING

Nutrition Supplement for Cystic Fibrosis

Lead Sponsor:

Ohio State University

Conditions:

Cystic Fibrosis (CF)

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The goal of this study is to learn if one nutrition supplement formula works better than a different formula in adults with cystic fibrosis. The main question being addressed is: Will certain atypical...

Detailed Description

Background. For people with cystic fibrosis (CF), new drugs have extended life expectancy and improved quality of life. Yet, even with these improvements, people with CF still face shorter than normal...

Eligibility Criteria

Inclusion

  • Diagnosed with cystic fibrosis
  • Diagnosed with exocrine pancreatic insufficiency
  • 18 years old or older
  • Currently on modulator
  • Normal liver enzyme labs

Exclusion

  • :
  • Non-English-speaking participants
  • Acute health crisis
  • Persistent elevation of liver enzymes \>6 months (E2) (ALT \>80 U/L)
  • History of liver abnormalities
  • If patients are currently taking Category A or Category B in the LiverTox categorization system
  • Recent vitamin D supplementation of 30 mcg/day or higher, vitamin E supplements of 200 IU/day or higher, or copper at 2 mg/day or higher
  • Any other concern by investigator that the subject is inappropriate for inclusion
  • Patients who is on a reduced dose of a CFTR modulator
  • Patients on azole antifungals (voriconazole, itraconazole, posaconzole, \>7 days of fluconazole, etc.).
  • Patients who binge drink EtOH - for men more than 2 drinks/day, for women more than 1 drink/ day
  • Patients that are on other medications that are sensitive CYP3A4 substrates - such as tacrolimus for example
  • Patients on sensitive CYP3A4 substrates including but not limited to tacrolimus, sirolimus, and cyclosporine

Key Trial Info

Start Date :

January 15 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 27 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT07163078

Start Date

January 15 2026

End Date

April 27 2026

Last Update

December 19 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.